Mohammad G. Saklayen

Low-Dose Methotrexate for the Prevention of Atherosclerotic Events

Paul M. Ridker, Brendan M. Everett, Aruna D. Pradhan et al. · New England Journal of Medicine · 2018 · 1.2K citations · Full text

Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT)

Daniel E. Weiner, Sarah A. Gaussoin, John Nord et al. · American Journal of Kidney Diseases · 2017 · 78 citations · Full text

Renal Care, Psychiatry, Medicine +9

Increased urinary angiotensin converting enzyme 2 and neprilysin in patients with type 2 diabetes

Sridevi Gutta, Nadja Grobe, Meenasri Kumbaji et al. · American Journal of Physiology-Renal Physiology · 2018 · 67 citations · Full text

Hypertension, Immunology, Pathology +18

Predictive factors for high mortality in hypernatremic patients

Anil K. Mandal, Mohammad G. Saklayen, N Hillman et al. · The American Journal of Emergency Medicine · 1997 · 63 citations

Metabolic Syndrome, Longevity, High Mortality +3

Effects of Additive Therapy with Spironolactone on Proteinuria in Diabetic Patients Already on ACE Inhibitor or ARB Therapy: Results of a Randomized, Placebo-Controlled, Double-Blind, Crossover Trial

Mohammad G. Saklayen, Leonard K. Gyebi, Joseph Tasosa et al. · Journal of Investigative Medicine · 2008 · 63 citations